- Home
- CAPL vs IMTX Comparison
CAPL vs IMTX Comparison
Compare CAPL & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPL
- IMTX
- Stock Information
- Founded
- CAPL 1992
- IMTX N/A
- Country
- CAPL United States
- IMTX Germany
- Employees
- CAPL N/A
- IMTX N/A
- Industry
- CAPL Oil Refining/Marketing
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CAPL Energy
- IMTX Health Care
- Exchange
- CAPL Nasdaq
- IMTX Nasdaq
- Market Cap
- CAPL 847.3M
- IMTX 954.2M
- IPO Year
- CAPL 2012
- IMTX N/A
- Fundamental
- Price
- CAPL $22.70
- IMTX $5.42
- Analyst Decision
- CAPL
- IMTX Strong Buy
- Analyst Count
- CAPL 0
- IMTX 4
- Target Price
- CAPL N/A
- IMTX $16.67
- AVG Volume (30 Days)
- CAPL 42.6K
- IMTX 1.2M
- Earning Date
- CAPL 02-26-2025
- IMTX 03-20-2025
- Dividend Yield
- CAPL 9.27%
- IMTX N/A
- EPS Growth
- CAPL N/A
- IMTX N/A
- EPS
- CAPL 0.52
- IMTX N/A
- Revenue
- CAPL $3,856,840,000.00
- IMTX $128,824,447.00
- Revenue This Year
- CAPL $8.79
- IMTX $116.22
- Revenue Next Year
- CAPL N/A
- IMTX N/A
- P/E Ratio
- CAPL $43.22
- IMTX N/A
- Revenue Growth
- CAPL N/A
- IMTX 52.53
- 52 Week Low
- CAPL $18.43
- IMTX $5.20
- 52 Week High
- CAPL $23.60
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- CAPL 49.86
- IMTX 33.13
- Support Level
- CAPL $22.44
- IMTX $5.20
- Resistance Level
- CAPL $23.38
- IMTX $5.57
- Average True Range (ATR)
- CAPL 0.52
- IMTX 0.28
- MACD
- CAPL 0.00
- IMTX 0.04
- Stochastic Oscillator
- CAPL 31.29
- IMTX 20.00
About CAPL CrossAmerica Partners LP Common Units representing limited partner interests
CrossAmerica Partners LP is engaged in the wholesale distribution of motor fuel and the ownership and leasing of real estate used in the retail distribution of motor fuel. The company operates through two business segments namely Wholesale and Retail. The Wholesale segment is a key revenue driver, includes the wholesale distribution of motor fuel to lessee dealers, independent dealers, commission agents, DMS, Circle K and through company operated retail sites. The Retail segment includes the sale of convenience merchandise items, the retail sale of motor fuel at company-operated retail sites and the retail sale of motor fuel at retail sites operated by commission agents.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.